IL1B and atherosclerosis: Data linking IL-1β to atherosclerosis stem from early work demonstrated that a lack of IL-1β decreases the severity of atherosclerosis [60] and that administration of a monoclonal antibody targeted against IL-1β limits the progression of atherosclerosis in ApoE deficient mice [61].